发明名称 Processes for the preparation of key intermediate for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
摘要 The present invention relates in general to the field of organic chemistry and in particular to a process for the preparation of 5-((E)-2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethanesulfonylamino)pyrimidine (RSVL) as well as a process for preparing crystalline 5-((E)-2-((2S,4R)-4-(tert-butyldimethylsilyloxy)-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethanesulfonylamino)pyrimidine (RSVLTBS) useful as key intermediates for the preparation of rosuvastatin or pharmaceutically acceptable salts thereof.
申请公布号 US9067895(B2) 申请公布日期 2015.06.30
申请号 US201013515782 申请日期 2010.12.15
申请人 LEK PHARMACEUTICALS D.D. 发明人 Andrensek Samo;Anzel Jolanda;Hocevar Marjeta;Casar Zdenko
分类号 C07D239/02;C07D239/42;C07D405/06;C07F7/18 主分类号 C07D239/02
代理机构 Arent Fox LLP 代理人 Arent Fox LLP
主权项 1. A process for preparing the compound of formula RSVL comprising the steps of: providing a compound of formula RSVLTBS: converting the compound of formula RSVLTBS into the compound of formula RSVL by removal of silyl protection group in the presence of tetrabutyl ammonium fluoride and acid in organic solvent, and isolating said compound of formula RSVL, further purifying RSVL by extraction with methyl t-butyl ether and forming crystallized RSVL; and recrystallizing the crystallized RSVL using a solvent selected from a group consisting of ethanol, 2-propanol and ethyl acetate and forming recrystallized RSVL.
地址 Ljubljana SI